Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...

Across the observable universe, galaxies advertise themselves in radio waves for familiar reasons-magnetic fields, cosmic ...

At 3.51 au from the Sun well beyond the region where water ice normally drives strong cometary activity 3I/ ATLAS still ...

Northrop Grumman is a pure-play U.S. defense and space prime whose dominance in stealth bombers, missile defense, autonomous systems, and orbital infrastructure positions it at the center of America’s ...

BOCA CHICA BEACH, Texas — SpaceX launched Starship for its ninth test flight on Tuesday night, which also marked for the first time that a Super Heavy booster was reused for a second time. However, ...

As the only home sauna shown to almost entirely cancel both ELF and EMF (extremely low frequency and electromagnetic field), ...

Johnson & Johnson today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor ...

The Cellares Cell Shuttle platform was the first to receive the FDA’s Advanced Manufacturing Technology (AMT) designation, which offers partners additional touchpoints and priority review mechanisms ...

Autolus will evaluate Cellares' fully automated, high-throughput manufacturing platform in preparation for expansion into new indications Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage ...